Archive for July 27th, 2011

KERX AEZS complete perifosine enrolment. ADLR data August + AFFY ALXA CYTR

Jul 27, 2011 No Comments by

Affymax, Inc. (Nasdaq:AFFY) and Takeda Global Research and Development Center, Inc., U.S., today announced that the FDA accepted for review the NDA for peginesatide (formerly known as Hematide) for the treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis. Adolor Corporation (NasdaqGM: ADLR) today said it expects to report data […]

Daily News Read more